Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
OraLiva, Inc.
OraLiva provides lab-grade, point-of-care early cancer detection using a non-invasive brush sample to identify cellular signs of dysplasia in minutes. The company combines proprietary biosensing and…
OraLiva, Inc.
OraLiva provides lab-grade, point-of-care early cancer detection using a non-invasive brush sample to identify cellular signs of dysplasia in minutes. The company combines proprietary biosensing and…
TL;DR
Product: AI-powered brush-biopsy cytology platform (ONC INCYT) for point-of-care oral cancer/dysplasia detection
Founded: 2019
HQ: New York
Employees: 12
Recent funding: $2.0M Seed (Oct 2025) + ~$3.5M non-dilutive NIH/NSF awards
Company Overview
Problem Domain
Early detection of oral cancer and epithelial cancers via cytology-based diagnostics at point of care.
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
$2,000,000
Reported as an oversubscribed Seed round with participation from DCVC, RTP Angel Fund, and NYU Innovation Venture Fund
$3,500,000
Reported complementary NIH/NSF awards (NIH/NIDCR $1.9M; NSF $1.2M; NIH/NCI $400K)
Investor Signal
“Participation from DCVC, NYU Innovation Venture Fund, RTP Angel Fund and angel investor Preetpal Sidhu; company has NIH/NSF grant support”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week